In pharma areas like high potency APIs, sterile manufacturing capabilities, antibody drug conjugates, peptides etc are areas that are growing fast and there is an inherent entry barrier
The company will focus on its insurance distribution portfolio, moving away from making insurance products
Female founders had a median salary of Rs 1 cr, while their male counterparts earned a median of Rs 1.8 cr: Study
Affle (India) Ltd Q4 results: The company's revenue from operations increased by 42.26% to Rs 506.22 crore in Q4, compared to Rs 355.82 crore reported in the year before
Total business premium for the year ending March 31, 2024 grew by 62 per cent to Rs 1,871 crore
During FY23, the company maintained an average of 32,798 employees on its rolls, with 29,503 actively engaged
'This discourages many employers from hiring contract workers through recruitment agencies as they see the steep tax as an additional burden.'
ITC Q4FY24 results: The company board recommended a final dividend of Rs 7.50 per ordinary share of Rs 1 each for the financial year that ended on March 31, 2024
Litigation before courts in the US and arbitral tribunal in London settled, two sides say
Fintech giant has seen exits in its senior management after its banking unit was put under restrictions in January
The calls will be routed via Tata Communications' data centre in the Mumbai region, thereby helping organisations stay compliant with local regulations
Media house DB Corp Ltd on Wednesday reported a nearly three-fold jump in consolidated net profit at Rs 122.52 crore for the fourth quarter ended March 31, helped by a broad-based growth across verticals. The company had posted a consolidated net profit of Rs 41.02 crore in the January-March quarter a year ago, DB Corp said in a regulatory filing. Its revenue from operations was up 16.23 per cent to Rs 617.13 crore during the quarter under review. It was at Rs 530.95 crore in the corresponding period of the previous fiscal. The company said its total expenses in the March quarter was at Rs 480.23 crore, down 2.2 per cent. Its revenue from "printing, publishing and allied business" was up 15.42 per cent to Rs 576.28 crore in the March quarter of financial year 2023-24. While revenue from the radio business was at Rs 41.15 crore, up 29.28 per cent. "On a quarterly basis, Q4 FY24 saw broad-based growth for the 11th quarter in a row with 24.6 per cent growth in advertisement revenue
Private airline SpiceJet has already disbursed Rs 730 crore to Maran and his firm, of which, Rs 580 crore represents the principal amount, with an additional interest component of Rs 150 crore
A pillar of France's CAC 40 blue chip index, TotalEnergies is one of the world's largest oil companies
Once operational, the facility will mark the company's entry in the North Indian market
Tata Power Delhi Distribution on Tuesday said it has inked an initial pact with India Smart Grid Forum for the 'Vehicle-to-Grid Technology Demonstration Project'. The initiative aims to explore the potential of EVs to provide essential grid services like frequency and voltage support, test their viability as backup power sources during outages, and examine the impact of bi-directional charging, a company statement said. The pilot project aims to showcase the basics of how electric vehicles (EVs) can interact with the grid. This project looks at reducing carbon emissions within the transportation and energy sectors, Tata Power Delhi Distribution Ltd (Tata Power-DDL) which supplies electricity to a populace of 7 million in North Delhi, said.. Additionally, the project will investigate how EVs can participate in the power market by storing electricity when prices are low and selling it back during peak hours. It will also test the feasibility of charging EVs with green electricity. "T
Chemicals and fertilisers manufacturing company will expand domestic capacity and may look for tie-ups, says Ashwin Muthiah
Headhunting firm Egon Zehnder is currently evaluating potential candidates and is expected to present a shortlist to Bandhan Bank's board in the coming weeks
Company 'targeting gain in market share', says MD and CEO Prashant Tripathy
Company says approval is a 'significant milestone' and marks entry in new therapeutic area in the US